↓ Skip to main content

Translation of proteomic biomarkers into FDA approved cancer diagnostics: issues and challenges

Overview of attention for article published in Clinical Proteomics, October 2013
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

policy
1 policy source

Citations

dimensions_citation
354 Dimensions

Readers on

mendeley
425 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Translation of proteomic biomarkers into FDA approved cancer diagnostics: issues and challenges
Published in
Clinical Proteomics, October 2013
DOI 10.1186/1559-0275-10-13
Pubmed ID
Authors

Anna K Füzéry, Joshua Levin, Maria M Chan, Daniel W Chan

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 425 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Italy 2 <1%
United States 2 <1%
Malaysia 1 <1%
Netherlands 1 <1%
United Kingdom 1 <1%
Germany 1 <1%
Japan 1 <1%
Taiwan 1 <1%
Unknown 415 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 91 21%
Student > Ph. D. Student 85 20%
Student > Master 55 13%
Student > Bachelor 44 10%
Student > Doctoral Student 23 5%
Other 55 13%
Unknown 72 17%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 93 22%
Agricultural and Biological Sciences 83 20%
Medicine and Dentistry 49 12%
Chemistry 38 9%
Engineering 20 5%
Other 56 13%
Unknown 86 20%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 January 2016.
All research outputs
#8,882,501
of 26,017,215 outputs
Outputs from Clinical Proteomics
#112
of 347 outputs
Outputs of similar age
#78,702
of 224,343 outputs
Outputs of similar age from Clinical Proteomics
#3
of 5 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. This one is in the 42nd percentile – i.e., 42% of other outputs scored the same or lower than it.
So far Altmetric has tracked 347 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.4. This one has gotten more attention than average, scoring higher than 57% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 224,343 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 46th percentile – i.e., 46% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 5 others from the same source and published within six weeks on either side of this one. This one has scored higher than 2 of them.